Navigation Links
Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Date:8/28/2007

ss than $35 million, compared to original guidance estimates of approximately $40 million. Sunesis expects its 2008 cash used in operating activities to be at or below its 2007 level.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. Sunesis has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. Sunesis is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

Safe Harbor Statement

This press release contains forward-looking statements including without limitation statements related to the safety and potential efficacy of SNS-595, SNS-032 and SNS-314, planned additional clinical testing and development efforts, the anticipated timing of the commencement and completion of clinical trials and the announcement of clinical results, whether any future trial will constitute a registration trial sufficient to support an application for regulatory approval, potential corporate partnerships or collaborations, plans to strategically invest in drug discovery efforts, ability to advance high-quality lead candidates into preclinical and clinical development, the estimated reduction in Sunesis' operating expenses, the estimated restructuring charges to be incurred in the third quarter, and Sunesis' ongoing cash requirements . Words such as "anticipates," "plans," "will," "optimistic," "is expected" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... AUSTIN, Texas , Dec. 24, 2014 /PRNewswire/ ... company focused on gynecologic disease, announced today that ... with investors including Oracle Investment Management, Jack ... Vermillion directors. Total proceeds were $10.5 million, before ... working capital and general corporate purposes. ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 ... series is designed to introduce cutting edge ... users and partners of platform upgrades. This ... benefits; empowering users in their quest to ... tools. , According to SoundConnect’s Marketing Manager, ...
(Date:12/24/2014)... The report expects global cell isolation and ... also provides a carefully analyzed data about the vital ... market. , Full Copy of Report @ http://bit.ly/1yUxy0T ... for cell expansion will keep witnessing growth at an ... to be driven by rapid technological advancements, government funding ...
(Date:12/24/2014)... Sigma-Aldrich Corporation (NASDAQ: SIAL ... the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in ... 2014, thereby completing the U.S. HSR Act antitrust ... the Company by Merck KGaA, Darmstadt, Germany.  ... to closing the transaction, which remains subject to ...
Breaking Biology Technology:Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3
... 24, 2011 ValGenesis, Inc., an industry-leading provider ... announced the availability of its industry-proven solution as ... hosted on MUSA,s Validated Cloud. ValGenesis ... solution accessible via the Internet through MUSA,s Validated ...
... announces that a new market research report is available ... and Global Markets http://www.reportlinker.com/p0461667/Quantum-Dots-Technologies-and-Global-Markets.html ... in 2010 was worth an estimated $67 million in ... next 5 years at a compound annual growth rate ...
... March 23, 2011 Novavax, Inc. (Nasdaq: NVAX ... financial results in a press release to be issued after ... then hold an investor conference call at 10:00 a.m. The ... Officer, Dr. Rahul Singhvi and other members of senior management. ...
Cached Biology Technology:Announcing ValGenesis On-Demand SaaS Solution 2Announcing ValGenesis On-Demand SaaS Solution 3Reportlinker Adds Quantum Dots: Technologies and Global Markets 2Reportlinker Adds Quantum Dots: Technologies and Global Markets 3Reportlinker Adds Quantum Dots: Technologies and Global Markets 4Reportlinker Adds Quantum Dots: Technologies and Global Markets 5Reportlinker Adds Quantum Dots: Technologies and Global Markets 6Reportlinker Adds Quantum Dots: Technologies and Global Markets 7Reportlinker Adds Quantum Dots: Technologies and Global Markets 8Reportlinker Adds Quantum Dots: Technologies and Global Markets 9Reportlinker Adds Quantum Dots: Technologies and Global Markets 10Reportlinker Adds Quantum Dots: Technologies and Global Markets 11Reportlinker Adds Quantum Dots: Technologies and Global Markets 12Reportlinker Adds Quantum Dots: Technologies and Global Markets 13Reportlinker Adds Quantum Dots: Technologies and Global Markets 14Reportlinker Adds Quantum Dots: Technologies and Global Markets 15Reportlinker Adds Quantum Dots: Technologies and Global Markets 16Reportlinker Adds Quantum Dots: Technologies and Global Markets 17Reportlinker Adds Quantum Dots: Technologies and Global Markets 18Reportlinker Adds Quantum Dots: Technologies and Global Markets 19Reportlinker Adds Quantum Dots: Technologies and Global Markets 20
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... addition of the "iPhone 5S Fingerprint Sensor ... report to their offering. ... acquisition of AuthenTec in July 2012, Apple introduced ... It is currently the only device of Apple ...
(Date:12/17/2014)... , Dec. 15, 2014 The Defense ... it easier to detect and prevent counterfeit microcircuits ... Today the agency started performing an in-house microcircuit ... validate the authenticity of purchased microcircuits while increasing ... quality control measures will be conducted at DLA,s ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... a secret code, but you could see only part of ... trying to identify proteins and characterize how those proteins are ... researchers have extended a powerful technique to increase by fourfold ... those containing more than 2,000 amino acids, up from about ...
... the past five years, Dr. Erika Dyck has been ... pioneering psychiatrists who worked in Saskatchewan, Canada in the ... University of Alberta history of medicine professor has found ... dose of the hallucinogenic drug LSD, provided in a ...
... use their whiskers to explore their environment and to ... example, use their whiskers to determine the size, shape ... to track the fluid wakes of their prey. ... whisker system of rats to better understand how mechanical ...
Cached Biology News:New technique boosts size of proteins that can be analyzed 2LSD treatment for alcoholism gets new look 2LSD treatment for alcoholism gets new look 3Robotic whiskers can sense three-dimensional environment 2
... electrophoresis into an automated, high-throughput operation with ... system is ideal for analyzing multiple PCR ... Fully automated, robot-compatible, and ready to put ... your high-throughput screening assignments as easy as ...
...
SpectroQuest single beam 4nm UV/Vis spectrophotometer; stand-alone unit; large angled LCD screen; large sample compartment...
Fluorescence Preserving Media, 100 mL...
Biology Products: